Medical Expenditure Panel
Survey (MEPS) COVID-19 Changes
Revision of a currently approved collection
No
Regular
10/05/2022
Requested
Previously Approved
36 Months From Approved
11/30/2023
392,715
379,377
88,531
88,309
0
0
The questions will be asked of all
MEPS sample members with a single household respondent reporting
for the household. The first two questions serve as gate questions
and only respondents who report having a COVID-19 diagnosis in the
relevant time period will receive follow-up questions about the
timing of their most recent infection. These questions will be
administered in the existing Priority Conditions Enumeration
section of MEPS, which includes a similar series of questions about
whether household members have ever been diagnosed with certain
medical conditions. Historically, MEPS has been conducted using
Computer Assisted Personal Interviewing (CAPI) where field
interviews conduct interviews with household respondents in person.
However, MEPS is currently being conducted via multiple modes,
including face-to-face, phone, and virtual interviewing, due to the
ongoing COVID-19 pandemic. The information collected on COVID-19
diagnoses will undergo editing and be reviewed for data quality,
including consistency with publicly available sources of data on
COVID-19 infections. Additionally, the resulting variables will be
included on the annual MEPS full-year consolidated public use data
files after being assessed for any potential disclosure concerns.
The new CAPI questions collecting information about COVID-19 will
be folded into the regular processing stream of MEPS data to
produce estimates of health care utilization and expenditures. The
information collected on COVID-19 diagnoses will be used to compare
healthcare utilization and expenditures between those who have had
confirmed COVID-19 and those who have not. Additionally, the
information collected on the timing of recent infections can be
used to either include or exclude recent infections from calendar
year or round-specific estimates of healthcare utilization and
expenditures. This allows researchers to examine both shorter-term
and longer-term impacts of a COVID-19 diagnosis on healthcare
utilization and expenditures.
US Code:
42
USC 299 Name of Law: Agency for Healthcare Research and Quality
Act of 1999
The total estimated annual
burden hours for the MEPS have increased from 88,309 hours in the
previous clearance to 88,531 hours in this clearance request, an
increase of 222 hours due to the addition of the COVID-19 related
questions.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.